Position in FLGT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$133,655
New position
Shares Held
8,406
first reported quarter
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Freestone Grove Partners LP holds $254,069,772 across 12 Diagnostics & Research names. FLGT ranks #11 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
338,698 | $64,217,140 | |
| 2 | A |
Agilent Technologies, Inc.
|
474,435 | $54,076,101 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
90,516 | $50,860,035 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
203,851 | $34,764,749 | |
| 5 | QGEN |
Qiagen N.V.
|
661,857 | $26,500,754 | |
| 6 | RDNT |
RadNet, Inc.
|
365,394 | $20,421,870 | |
| 7 | DGX |
Quest Diagnostics Inc
|
5,690 | $1,115,126 | |
| 8 | LH |
Labcorp Holdings Inc.
|
3,713 | $990,665 |
All Filings in FLGT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $133,655 | 8,406 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||